Evolent Health
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $621,401 | $647,145 | $639,653 | $556,055 |
Gross Profit | 80,693 | 76,673 | 74,603 | 101,627 |
EBITDA | 11,955 | 40,442 | 18,785 | -6,227 |
EBIT | -17,746 | 9,458 | -10,718 | -35,829 |
Net Income | -23,137 | 1,596 | -17,280 | -33,411 |
Net Change In Cash | 621,401 | 647,145 | 639,653 | 556,055 |
Free Cash Flow | 12,381 | 14,311 | -438 | 83,329 |
Cash | 96,583 | 121,303 | 216,741 | 192,825 |
Basic Shares | 114,862 | 114,688 | 114,141 | 113,588 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $1,963,896 | $1,352,013 | $907,957 | $1,022,433 |
Gross Profit | 460,470 | 316,584 | 250,406 | 321,060 |
EBITDA | -24,785 | 43,746 | 55,661 | -241,380 |
EBIT | -148,200 | -46,505 | -4,376 | -302,215 |
Net Income | -113,040 | -18,701 | -30,284 | -334,246 |
Net Change In Cash | 1,963,896 | 1,352,013 | 907,957 | 1,022,433 |
Cost of Revenue | -139,127 | -6,587 | 232,985 | |
Free Cash Flow | 113,837 | -49,914 | 13,764 | -45,698 |
Cash | 192,825 | 188,200 | 266,280 | 340,490 |
Basic Shares | 111,251 | 93,699 | 86,067 | 84,928 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | $0.04 |
2024-06-30 | $0.30 |
2024-03-31 | $0.34 |
2023-12-31 | $0.23 |
